Levilimab Clinical Efficacy for Interleukin-6 Receptor Inhibition in COVID-19 and Its Potential for Treating Cytokine Release Syndrome of Other Aetiologies

N. V. Lomakin,B. A. Bakirov, G. H. Musaev, V. V. Popov,E. A. Smolyarchuk,Yu. N. Linkova, D. V. Bogdan,A. V. Eremeeva,P. S. Pukhtinskaia,M. A. Morozova,A. V. Zinkina-Orikhan,A. A. Lutckii

Biopreparaty Profilaktika, diagnostika, lečenie（2022）

引用 0|浏览9

暂无评分

关键词

levilimab,covid-19,interleukin-6,cytokine release syndrome,acute respiratory distress syndrome,hyperinflammatory syndrome,pathogenesis-oriented therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要